Ponatinib Inhibits Proliferation and Induces Apoptosis of Liver Cancer Cells, but Its Efficacy Is Compromised by Its Activation on PDK1/Akt/mTOR SignalingChang Liu(Shanxi Medical University), Gongqin Sun(University of Rhode Island)MoleculesApril 7, 201910.3390/molecules24071363Cited by 29SaveCiteExport RISWatch citationsRelated PapersDrug Sensitivity Screening and Targeted Pathway Analysis Reveal a Multi-Driver Proliferative Mechanism and Suggest a Strategy of Combination Targeted Therapy for Colorectal Cancer Cells|Molecules|2019|10Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells|Cancers|2020|8Structural versatility that serves the function of the HRD motif in the catalytic loop of protein tyrosine kinase, Src|Protein Science|2018|7Targeting B4GALT7 suppresses the proliferation, migration and invasion of hepatocellular carcinoma through the Cdc2/CyclinB1 and miR-338-3p/MMP2 pathway|PeerJ|2023|5